"10.1371_journal.pone.0109610","plos one","2014-10-08T00:00:00Z","Zhuochun Peng; Karl Andersson; Johan Lindholm; Inger Bodin; Setia Pramana; Yudi Pawitan; Monica Nistér; Sten Nilsson; Chunde Li","Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Radiology and Radiation Sciences, Uppsala University, Uppsala, Sweden; Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Clinical Oncology, Karolinska University Hospital, Stockholm, Sweden; Chundsell Medicals AB, Stockholm, Sweden; Ridgeview Instruments AB, Uppsala, Sweden; Sekolah Tinggi Ilmu Statistik/Institute of Statistics, Jakarta, Indonesia","Conceived and designed the experiments: ZP KA JL IB SP YP MN SN CL. Performed the experiments: ZP JL IB. Analyzed the data: KA ZP. Contributed reagents/materials/analysis tools: ZP JL IB KA. Wrote the paper: ZP KA.","Dr. Chunde Li is one of the co-founders, a shareholder and deputy of the board of directors of Chundsell Medicals AB, a start-up company aiming at developing a Prostatype ® qRT-PCR kit based on the previously reported signature study mentioned in References. He is also one of the inventors of Swedish patent (SE 536352), owned by Chundsell Medicals AB. Zhuochun Peng works as a scientific consultant and product manager for Chundsell Medicals AB, in addition to being a shareholder. She is also one of the inventors of a Swedish patent (SE 536352), owned by Chundsell Medicals AB. Karl Andersson works as a statistics consultant for Chundsell Medicals AB. He is affiliated with the Ridgeview Instruments AB, which is a contractual developer for Chundsell Medicals AB. The above disclosed competing interest does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","10","Zhuochun Peng","ZP",9,TRUE,9,3,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
